AMGEN INC - Common Stock (AMGN) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2014 to Q4 2025

Type / Class
Equity / Common Stock
Symbol
AMGN on Nasdaq
Shares outstanding
538,607,950
Price per share
$366.20
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
433,614,062
Total reported value
$141,810,550,080
% of total 13F portfolios
0.11%
Share change
+11,272,440
Value change
+$3,712,760,396
Number of holders
3,010
Price from insider filings
$366.20
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of AMGEN INC - Common Stock (AMGN) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
VANGUARD GROUP INC 10% $15,524,296,943 53,860,795 The Vanguard Group 29 Aug 2025
BlackRock, Inc. 7.6% $11,782,144,305 40,830,830 BlackRock, Inc. 31 Mar 2025

As of 31 Dec 2025, 3,010 institutional investors reported holding 433,614,062 shares of AMGEN INC - Common Stock (AMGN). This represents 81% of the company’s total 538,607,950 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of AMGEN INC - Common Stock (AMGN) together control 55% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
VANGUARD GROUP INC 10% 54,838,826 +1.8% 0.26% $17,949,296,138
BlackRock, Inc. 8.8% 47,396,138 +3% 0.26% $15,513,229,833
STATE STREET CORP 5.7% 30,591,403 +4.4% 0.34% $10,012,872,116
Capital World Investors 4.3% 23,097,711 +23% 1% $7,560,249,344
Capital International Investors 3.4% 18,186,270 -5.2% 0.93% $5,952,964,722
MORGAN STANLEY 2.9% 15,744,528 -1% 0.31% $5,153,342,607
GEODE CAPITAL MANAGEMENT, LLC 2.7% 14,303,294 +7.8% 0.29% $4,665,822,333
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 2.2% 11,811,045 -13% 0.6% $3,865,873,139
PRIMECAP MANAGEMENT CO/CA/ 1.7% 8,904,979 -8.3% 2.2% $2,914,688,677
WELLS FARGO & COMPANY/MN 1.3% 7,110,693 -0.65% 0.46% $2,327,400,741
NORGES BANK 1.2% 6,611,965 0.23% $2,164,162,264
NORTHERN TRUST CORP 1.1% 6,181,658 +0.61% 0.26% $2,023,318,481
BANK OF AMERICA CORP /DE/ 1% 5,537,361 +6.8% 0.13% $1,812,433,488
Invesco Ltd. 0.89% 4,788,460 +7.2% 0.24% $1,567,310,831
ROYAL BANK OF CANADA 0.87% 4,704,930 +3.8% 0.27% $1,539,969,000
Capital Research Global Investors 0.86% 4,648,155 -1.8% 0.28% $1,521,390,119
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC 0.85% 4,604,019 +1.2% 0.32% $1,506,941,458
GOLDMAN SACHS GROUP INC 0.84% 4,529,203 +1.9% 0.21% $1,482,453,292
UBS Group AG 0.76% 4,104,524 -3% 0.27% $1,343,451,751
Bank of New York Mellon Corp 0.73% 3,907,016 -1.8% 0.23% $1,278,805,259
Legal & General Group Plc 0.71% 3,811,451 +2.5% 0.28% $1,247,526,029
FMR LLC 0.67% 3,592,220 +5.5% 0.06% $1,175,769,605
Amundi 0.63% 3,396,945 +41% 0.34% $1,111,854,069
Aristotle Capital Management, LLC 0.61% 3,292,564 -5.2% 2.2% $1,077,711,633
DIMENSIONAL FUND ADVISORS LP 0.6% 3,230,979 +1.6% 0.22% $1,057,561,123

Institutional Holders of AMGEN INC - Common Stock (AMGN) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 433,614,062 $141,810,550,080 +$3,712,760,396 $327.31 3,010
2025 Q3 422,518,278 $119,204,178,363 -$2,429,787,255 $282.20 2,796
2025 Q2 431,017,097 $120,366,553,868 +$2,450,274,027 $279.21 2,823
2025 Q1 422,473,345 $131,531,727,085 +$1,872,368,258 $311.55 2,896
2024 Q4 417,086,000 $108,720,772,463 +$2,265,838,363 $260.64 2,826
2024 Q3 406,369,935 $130,879,980,495 -$1,604,998,262 $322.21 2,806
2024 Q2 411,362,744 $128,504,192,197 +$1,181,157,825 $312.45 2,765
2024 Q1 407,436,623 $115,716,365,294 -$702,198,897 $284.32 2,693
2023 Q4 409,933,148 $118,123,741,660 +$1,005,699,600 $288.02 2,696
2023 Q3 405,531,200 $109,011,181,196 +$229,042,644 $268.76 2,487
2023 Q2 404,699,813 $89,947,908,938 -$261,931,019 $222.02 2,372
2023 Q1 404,701,714 $97,834,318,909 -$700,557 $241.75 2,415
2022 Q4 406,077,834 $106,668,591,111 -$748,747,430 $262.64 2,484
2022 Q3 409,616,600 $92,417,131,362 -$750,583,865 $225.40 2,296
2022 Q2 412,985,046 $100,492,204,105 -$1,259,144,735 $243.30 2,339
2022 Q1 421,058,516 $101,841,258,918 -$694,689,820 $241.82 2,318
2021 Q4 423,515,516 $95,315,634,243 -$510,096,720 $224.97 2,274
2021 Q3 423,973,569 $90,218,106,763 -$1,797,171,529 $212.65 2,117
2021 Q2 432,834,503 $105,480,060,350 -$1,552,090,464 $243.75 2,177
2021 Q1 438,906,620 $109,131,112,493 +$244,673,177 $248.81 2,198
2020 Q4 438,719,413 $100,855,504,433 -$1,555,161,163 $229.92 2,206
2020 Q3 445,447,041 $113,064,795,230 -$1,516,037,134 $254.16 2,112
2020 Q2 451,020,430 $106,377,849,041 +$196,760,550 $235.86 2,080
2020 Q1 450,778,286 $91,483,976,180 -$1,036,425,103 $202.73 2,021
2019 Q4 455,053,392 $109,666,060,331 -$1,402,308,815 $241.07 2,095
2019 Q3 460,409,362 $89,117,233,590 -$453,773,888 $193.51 1,872
2019 Q2 462,969,714 $85,284,004,074 -$1,977,498,329 $184.28 1,855
2019 Q1 477,538,680 $90,681,462,101 -$2,771,862,070 $189.98 1,866
2018 Q4 492,365,399 $95,762,097,851 -$1,211,016,167 $194.67 1,876
2018 Q3 497,801,083 $103,120,954,410 -$981,718,315 $207.29 1,786
2018 Q2 502,315,893 $92,666,956,468 -$4,399,362,488 $184.59 1,750
2018 Q1 526,674,425 $89,730,269,200 -$8,140,837,372 $170.48 1,744
2017 Q4 574,140,506 $99,788,178,222 -$661,000,207 $173.90 1,729
2017 Q3 576,679,315 $107,493,711,793 +$76,885,293 $186.45 1,602
2017 Q2 576,364,305 $99,237,997,064 +$56,253,074 $172.23 1,590
2017 Q1 584,054,105 $95,822,511,549 +$8,279,146,194 $164.07 1,596
2016 Q4 582,115,959 $85,116,893,980 -$2,283,535,896 $146.21 1,535
2016 Q3 595,353,468 $99,250,036,890 -$524,318,492 $166.81 1,508
2016 Q2 598,011,068 $91,002,814,954 -$665,380,765 $152.15 1,465
2016 Q1 602,391,544 $90,302,284,138 -$510,698,255 $149.93 1,428
2015 Q4 606,076,643 $98,347,152,747 -$591,914,368 $162.33 1,451
2015 Q3 609,131,462 $84,255,457,476 +$50,194,517 $138.32 1,369
2015 Q2 608,973,000 $93,498,836,731 -$1,138,005,047 $153.52 1,359
2015 Q1 616,070,989 $98,487,680,757 -$157,310,980 $159.85 1,336
2014 Q4 617,323,710 $98,338,715,975 +$380,063,709 $159.29 1,328
2014 Q3 615,195,343 $86,408,217,315 +$1,598,394,252 $140.46 1,211
2014 Q2 603,882,660 $71,496,939,408 +$316,677,506 $118.37 1,179
2014 Q1 601,707,083 $74,167,753,469 -$844,883,264 $123.34 1,168